CTLA4 and neoplasm: The mechanism of this phenomenon is still unrecognized, although in mouse models lacking CD4+ or CD8+ T cells the anti-CTLA-4 and anti-PD-1 treatment promoted normalization of tumor vessels via Th1 CD4+ helper T cell activation [35].